Published in Kidney Int on July 01, 2002
Pathophysiology of acute kidney injury. Compr Physiol (2012) 1.56
Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells. Am J Pathol (2004) 0.98
Zinc-mediated allosteric inhibition of caspase-6. J Biol Chem (2012) 0.92
l-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice. Front Immunol (2013) 0.84
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
The role of iron in diabetes and its complications. Diabetes Care (2007) 2.07
Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury. Kidney Int (2009) 1.91
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90
Meprin, a brush-border enzyme, plays an important role in hypoxic/ischemic acute renal tubular injury in rats. Kidney Int (2002) 1.74
Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells. Am J Physiol Renal Physiol (2008) 1.71
Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease. Kidney Int (2011) 1.58
p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury. J Biol Chem (2005) 1.52
Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells. Am J Physiol Renal Physiol (2004) 1.43
Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. J Clin Virol (2009) 1.43
Improving outcomes of acute kidney injury: report of an initiative. Nat Clin Pract Nephrol (2007) 1.38
Apoptotic pathways in ischemic acute renal failure. Kidney Int (2004) 1.35
Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi process. Clin J Am Soc Nephrol (2008) 1.30
Improving outcomes from acute kidney injury: report of an initiative. Am J Kidney Dis (2007) 1.26
Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity. Autophagy (2008) 1.24
Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int (2005) 1.22
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials. Clin J Am Soc Nephrol (2012) 1.20
New insights into nephrogenic systemic fibrosis. J Am Soc Nephrol (2007) 1.20
Generation of biologically active interleukin-1beta by meprin B. Cytokine (2005) 1.20
Chronic uremia stimulates LDL carbamylation and atherosclerosis. J Am Soc Nephrol (2010) 1.17
Improving outcomes from acute kidney injury: report of an initiative. Pediatr Nephrol (2007) 1.15
PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G. Am J Physiol Renal Physiol (2004) 1.14
Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases. Am J Physiol Renal Physiol (2005) 1.13
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clin J Am Soc Nephrol (2012) 1.13
zVAD-fmk prevents cisplatin-induced cleavage of autophagy proteins but impairs autophagic flux and worsens renal function. Am J Physiol Renal Physiol (2012) 1.12
Carbamylated low-density lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol (2007) 1.11
Cisplatin nephrotoxicity is mediated by deoxyribonuclease I. J Am Soc Nephrol (2005) 1.09
Non-apoptotic effects of antiapoptotic agent zVAD-fmk in renal injury. Kidney Int (2013) 1.09
Activation of ERK or inhibition of JNK ameliorates H(2)O(2) cytotoxicity in mouse renal proximal tubule cells. Kidney Int (2004) 1.09
Actinonin, a meprin A inhibitor, protects the renal microcirculation during sepsis. Shock (2011) 1.05
Nephrogenic systemic fibrosis, gadolinium, and iron mobilization. N Engl J Med (2007) 1.05
Meprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1beta. Biochem Biophys Res Commun (2009) 1.03
Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium. Leuk Res (2004) 1.00
Meprin A metalloproteinase and its role in acute kidney injury. Am J Physiol Renal Physiol (2013) 0.99
Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway. Am J Physiol Heart Circ Physiol (2006) 0.99
Quantification of carbamylated LDL in human sera by a new sandwich ELISA. Clin Chem (2005) 0.98
Fibrate prevents cisplatin-induced proximal tubule cell death. Kidney Int (2005) 0.98
Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. Arterioscler Thromb Vasc Biol (2009) 0.98
Apoptotic pathways of oxidative damage to renal tubular epithelial cells. Antioxid Redox Signal (2002) 0.95
Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells. Nephrology (Carlton) (2008) 0.94
Ceramide synthase is essential for endonuclease-mediated death of renal tubular epithelial cells induced by hypoxia-reoxygenation. Am J Physiol Renal Physiol (2004) 0.94
Radiation nephropathy is not mitigated by antagonists of oxidative stress. Radiat Res (2009) 0.93
Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells. Am J Physiol Renal Physiol (2007) 0.93
Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck. Cancer Lett (2003) 0.93
Regulation of caspase-3 and -9 activation in oxidant stress to RTE by forkhead transcription factors, Bcl-2 proteins, and MAP kinases. Am J Physiol Renal Physiol (2004) 0.93
CREB mediates ERK-induced survival of mouse renal tubular cells after oxidant stress. Kidney Int (2005) 0.92
Role of coagulation and fibrinolytic system in prostate cancer. Semin Thromb Hemost (2003) 0.92
Endonuclease G promotes cell death of non-invasive human breast cancer cells. Exp Cell Res (2006) 0.92
Sensitivity of human prostate cancer cells to chemotherapeutic drugs depends on EndoG expression regulated by promoter methylation. Cancer Lett (2008) 0.92
World Kidney Day: an idea whose time has come. J Am Soc Nephrol (2006) 0.92
Endonuclease G mediates endothelial cell death induced by carbamylated LDL. Am J Physiol Heart Circ Physiol (2011) 0.91
Induction of renal endonuclease G by cisplatin is reduced in DNase I-deficient mice. J Am Soc Nephrol (2007) 0.90
DNase I-like endonuclease in rat kidney cortex that is activated during ischemia/reperfusion injury. J Am Soc Nephrol (2002) 0.89
Acute renal failure: directions for the next decade. J Am Soc Nephrol (2003) 0.89
Alteration of renal respiratory Complex-III during experimental type-1 diabetes. BMC Endocr Disord (2009) 0.89
Novel approaches targeted toward oxidative stress for the treatment of chronic kidney disease. Curr Opin Nephrol Hypertens (2008) 0.89
Prevention of cisplatin-induced kidney epithelial cell apoptosis with a Cu superoxide dismutase-mimetic [copper2II(3,5-ditertiarybutylsalicylate)4(ethanol)4]. Toxicol In Vitro (2006) 0.88
Iron and diabetes revisited. Diabetes Care (2011) 0.88
Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney Int (2009) 0.88
Suramin: a potential therapy for diabetic nephropathy. PLoS One (2013) 0.86
Association of catalytic iron with cardiovascular disease. Am J Cardiol (2011) 0.86
Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity. Biochem Pharmacol (2009) 0.86
The role of catalytic iron in acute kidney injury. Clin J Am Soc Nephrol (2011) 0.86
Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis. Am J Pathol (2013) 0.83
ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A. J Biol Chem (2014) 0.83
Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease. J Ren Nutr (2012) 0.82
Carbamylated LDL. Adv Clin Chem (2010) 0.82
Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease. Toxicol Mech Methods (2012) 0.81
Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains. Biochim Biophys Acta (2011) 0.81
Rapid improvement of nephrogenic systemic fibrosis with rapamycin therapy: possible role of phospho-70-ribosomal-S6 kinase. J Am Acad Dermatol (2010) 0.81
Combination inhibition of the renin-angiotensin system: is more better? Kidney Int (2011) 0.81
The Third World Kidney Day: looking back and thinking forward. Clin J Am Soc Nephrol (2008) 0.80
Metal deposition in calcific uremic arteriolopathy. J Am Acad Dermatol (2009) 0.78
World Kidney Day: an idea whose time has come. Am J Kidney Dis (2006) 0.78
World Kidney Day: an idea whose time has come. Kidney Int (2006) 0.77
Carbamylated-oxidized LDL: proatherosclerotic effects on endothelial cells and macrophages. J Atheroscler Thromb (2013) 0.76
Adult Patient with Novel H1N1 Infection Presented with Encephalitis, Rhabdomyolysis, Pneumonia and Polyneuropathy. J Glob Infect Dis (2012) 0.76
Epigenetic regulation of KLK7 gene expression in pancreatic and cervical cancer cells. Biol Chem (2016) 0.76
Kidney-liver dialogue in acute kidney injury. Am J Physiol Renal Physiol (2012) 0.75
Caspase protocols in mice. Methods Mol Biol (2014) 0.75
Kidney disease as an independent risk factor for cardiovascular events. J Ren Nutr (2005) 0.75
Endothelial dysfunction in antiangiogenesis-associated thrombosis. J Clin Oncol (2002) 0.75
Cytochrome P450 2B1 mediates complement-dependent sublytic injury in a model of membranous nephropathy. J Biol Chem (2010) 0.75
Letter to the editor regarding 'Acute phase reaction to gadolinium-DTPA in dialysis patients'. Nephrol Dial Transplant (2009) 0.75